Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of British Columbia

$27,000.00

Harnessing mitochondrial biology: Investigating CHCHD2’s role in improving CAR-T Cell metabolic fitness and function for cancer immunotherapy

FY 2024-25

Summary
T cells are a key component of the body cancer defence system. This has led to the development of new cancer treatments that equip a patient own T cells to target and kill cancer cells. This can be curative for certain blood cancers; however, for many others, including solid tumours, the success has been limited. One of the reasons for this lack of success is the ability of cancers to shroud themselves from the immune system. This happens in many ways. For instance, cancer cells can consume all the available biological fuel (e.g., sugars and other building blocks), that the T cells need for energy and growth, or tumours can produce chemicals to directly block the killing activity of T cells. A promising way to overcome this is by supercharging the T cells mitochondria, the powerhouses of the cell, to improve T cell resistance to the stress of battling cancer.Interestingly, a small protein called CHCHD2, can change the function of the mitochondria, particularly under stressful conditions; however, it has never been studied in T cells. We hypothesize that CHCHD2 could be used to boost the fitness of T cells to improve their ability to kill cancer cells. To test this, we will use new approaches to increase or remove CHCHD2 in T cells, testing if it contributes to their ability to kill cancer cells. We can assess T cell mitochondrial fitness by testing their ability to use biological fuels, as well as how effectively the mitochondria support the production of tumour-killing molecules by T cells.Ultimately, our research aims to prepare T cells to destroy cancers even in the most challenging environments. This has broad implications across many diseases, and it will also improve our fundamental understanding of the mitochondria and the immune system.
Program
Master's Award: Canada Graduate Scholarships
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
529649
Name
Kersey Braden
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Harnessing mitochondrial biology: Investigating CHCHD2’s role in improving CAR-T Cell metabolic fitness and function for cancer immunotherapy
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Adaptive Immunity; Cancer Immunotherapy; Car-T Cells; Cellular Metabolism; Cellular Stress Response; Immunometabolism; Mitochondrial Metabolism; Mitochondrial Structure; Oxidative Stress; Tumour Microenvironment
Abstract
T cells are a key component of the body cancer defence system. This has led to the development of new cancer treatments that equip a patient own T cells to target and kill cancer cells. This can be curative for certain blood cancers; however, for many others, including solid tumours, the success has been limited. One of the reasons for this lack of success is the ability of cancers to shroud themselves from the immune system. This happens in many ways. For instance, cancer cells can consume all the available biological fuel (e.g., sugars and other building blocks), that the T cells need for energy and growth, or tumours can produce chemicals to directly block the killing activity of T cells. A promising way to overcome this is by supercharging the T cells mitochondria, the powerhouses of the cell, to improve T cell resistance to the stress of battling cancer.Interestingly, a small protein called CHCHD2, can change the function of the mitochondria, particularly under stressful conditions; however, it has never been studied in T cells. We hypothesize that CHCHD2 could be used to boost the fitness of T cells to improve their ability to kill cancer cells. To test this, we will use new approaches to increase or remove CHCHD2 in T cells, testing if it contributes to their ability to kill cancer cells. We can assess T cell mitochondrial fitness by testing their ability to use biological fuels, as well as how effectively the mitochondria support the production of tumour-killing molecules by T cells.Ultimately, our research aims to prepare T cells to destroy cancers even in the most challenging environments. This has broad implications across many diseases, and it will also improve our fundamental understanding of the mitochondria and the immune system.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Kersey, Braden
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~